Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Fundación Para La Investigación Médica Aplicada holds a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio currently includes 1 pending office action. This action is assigned to 1 distinct examiner and 1 distinct art unit. RODRIGUEZ, RAYNA B is the busiest examiner, with 1 pending office action. The prosecution of this portfolio is currently focused on 1 pending office action being reviewed by 1 distinct examiner.
The involvement of 1 distinct art unit indicates that the Biotechnology & Pharmaceuticals technology is being evaluated within a specific group. Practitioners should focus on the specific requirements of RODRIGUEZ, RAYNA B to resolve the 1 pending office action. The examiner's individual interpretation of the 1 pending office action will be the primary factor in the company's patenting progress. Practitioners should focus on the specific requirements of the 1 distinct art unit to move the case forward. This focused approach allows for a dedicated response to the examiner's specific concerns regarding the 1 pending office action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RODRIGUEZ, RAYNA B | 1 | 33.6% | +19.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18034587 | ANDROGRAPHOLIDE DERIVATIVE FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES ASSOCIATED WITH A CYTOKINE STORM | RODRIGUEZ, RAYNA B | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18034587 | ANDROGRAPHOLIDE DERIVATIVE FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES ASSOCIATED WITH A CYTOKINE STORM | RODRIGUEZ, RAYNA B | — |
| Art Unit | Apps |
|---|---|
| 1628 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18034587 | ANDROGRAPHOLIDE DERIVATIVE FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES ASSOCIATED WITH A CYTOKINE STORM | RODRIGUEZ, RAYNA B | 1628 | §102§103§112 | Non-Final OA | — | Pending | Apr 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFundación Para La Investigación Médica Aplicada has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Rayna B Rodriguez has the most, with 1 of Fundación Para La Investigación Médica Aplicada's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
